Company Gene Biotherapeutics, Inc. Other OTC
Equities
CRXM
US8767671048
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 70 | 03-12-21 | |
James Grainer
CHM | Chairman | 69 | 20-05-21 |
Lois Chandler
COO | Chief Operating Officer | - | 10-06-30 |
Ronald Shebuski
CTO | Chief Tech/Sci/R&D Officer | 71 | 20-05-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 70 | 03-12-21 | |
James Grainer
CHM | Chairman | 69 | 20-05-21 |
Ronald Shebuski
CTO | Chief Tech/Sci/R&D Officer | 71 | 20-05-21 |
Kaushik Vyas
BRD | Director/Board Member | 68 | 20-05-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 64,931,888 | 60,931,888 ( 93.84 %) | 0 | 93.84 % |
Stock B | 0 | 498 | 0 | 0 |
Company contact information
Taxus Cardium Pharmaceuticals Group, Inc.
11230 Sorrento Valley Road Suite 220
92121, San Diego
+858 414 1477
http://www.genebiotherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+26.12% | 44.96B | |
+0.05% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.29% | 26.08B | |
-20.96% | 19.03B | |
+6.67% | 12.75B | |
+28.72% | 12.06B | |
-3.99% | 11.75B |